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Abstract
The reaction of lens proteins with sugars over time results in the formation of protein-bound advanced glycation end
products (AGEs). The most damaging element of AGE formation may be the synthesis of protein-protein cross-links in long-
lived proteins, such as collagen or lens crystallins. A quantitative cross-linking assay, involving the sugar-dependent
incorporation of [U-14C]lysine into protein, was employed to determine the efficacy of a variety of potential cross-linking
inhibitors. Reaction mixtures contained 5.0 mM L-threose, 2.5 WCi [14C]lysine (1.0 mCi/mmole), 5.0 mg/ml bovine lens
proteins, 0^10 mM inhibitor and 1.0 mM DTPA in 100 mM phosphate buffer, pH 7.0. Of 17 potential inhibitors tested,
11 showed 50% inhibition or less at 10 mM. The dicarbonyl-reactive compounds 2-aminoguanidine, semicarbazide and
o-phenylenediamine inhibited 50% at 2.0 mM, whereas 10 mM dimethylguanidine had no effect. Several amino acids failed to
compete effectively with [14C]lysine in the cross-linking assay; however, cysteine inhibited 50% at 1.0 mM. This was likely due
to the sulfhydryl group of cysteine, because 3-mercaptopropionic acid and reduced glutathione exhibited similar activity.
Sodium metabisulfite had the highest activity, inhibiting 50% at only 0.1^0.2 mM. Protein dimer formation, as determined by
SDS-PAGE, was inhibited in a quantitatively similar manner. The dicarbonyl-reactive inhibitors and the sulfur-containing
compounds produced similar inhibition curves for [14C]lysine incorporation over a 3 week assay with 250 mM glucose. A
much lesser effect was observed on either the incorporation of [14C]glucose, or on fluorophore formation (360/420 nm),
suggesting that non-cross-link fluorophores were also formed. The inhibitor data were consistent with cross-linking by a
dicarbonyl intermediate. This was supported by the fact that the inhibitors were uniformly less effective when the 5.0 mM
threose was replaced by either 3.0 mM 3-deoxythreosone or 3.0 mM threosone. ß 2001 Elsevier Science B.V. All rights
reserved.
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1. Introduction
The glycation of proteins via the Maillard reaction
in biological tissues is receiving increasing attention
in disease processes. While the addition of a glucose
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residue to protein amino groups has an e¡ect on
enzymes [1,2], the formation of advanced glycation
end products (AGEs) is potentially of greater impor-
tance [3,4]. These AGEs include protein cross-links,
£uorophores, browning products and residues re-
sponsible for oxygen free radical generation [5,6].
In long-lived proteins, cross-linking may be the
most signi¢cant component of the AGE modi¢ca-
tions, as it is likely responsible for the decreased
£exibility of collagen [7] and the formation of the
high level of urea-insoluble proteins seen in human
cataracts [8].
Several AGE cross-links have been isolated from
tissues [9,10], but more have been isolated from in
vitro reactions, and later demonstrated to be present
in tissue proteins [11^14]. The known AGE cross-
links are individually present in very low concentra-
tions even in diabetic tissues, and are extremely di⁄-
cult to isolate. What may be of greater signi¢cance to
tissue pathology is the total number of all the pro-
tein-protein AGE cross-links accumulated in the tis-
sue. Due to their potential role in disease, there is a
keen interest in ¢nding inhibitors of AGE cross-link
formation. 2-Aminoguanidine (2-AG) is e¡ective,
and can delay the onset of diabetic complications
in experimental animals, but high levels are required
to be e¡ective [15,16]. Many other inhibitors have
been reported, but their e⁄cacy has not been studied
in detail. These include competitive inhibitors of
glycation [17,18], 2-AG analogues that can poten-
tially react with dicarbonyl sugars [19], analgesics
[20] and enzyme cofactors [21,22] among others.
We have recently developed a quantitative assay
for AGE cross-linking, which measures the sugar-de-
pendent incorporation of [14C]lysine into protein
[23]. This assay uniquely measures the rate of forma-
tion of sugar-induced cross-links in a sensitive, quan-
titative and reproducible manner. It avoids the im-
precise measurements such as overall browning or
£uorophore formation, and is more quantitative
than estimating dimer and polymer bands in SDS-
PAGE gels. Therefore, the lysine incorporation assay
was employed to test a variety of compounds for
their ability to inhibit sugar-induced cross-linking.
In addition, it seemed possible that the chemical na-
ture of the most e¡ective inhibitors may shed some
light on the chemical mechanisms involved in AGE-
mediated cross-linking.
2. Materials and methods
2.1. Materials
[U-14C]Lysine (300 mCi/mmol) was purchased
from NEN Life Sciences (Wilmington, DE) and the
speci¢c activity decreased to 1.0 mCi/mmol by the
addition of [12C]lysine. Threosone and 3-deoxythreo-
sone were synthesized [24] and provided as a kind
gift by Mr. Gregory L. Simpson in our laboratory.
K-N-formyl-[U-14C]Lysine was synthesized by Dr.
Kwang-Won Lee as described previously [25]. All
inhibitors and reagents were obtained from Sigma
(St. Louis, MO) unless otherwise speci¢ed.
2.2. Quantitative assay for cross-linking
Reaction mixtures were prepared containing 5 mM
L-threose, 5.0 mg/ml water-soluble bovine lens pro-
teins, 2.5 WCi [14C]lysine (1.0 mCi/mmol), 10 mM of
each inhibitor, 1.0 mM diethylenetriaminepentaacetic
acid (DTPA) and 0.1 M phosphate bu¡er, pH 7.0 in
a total volume of 1.0 ml [23]. Each reaction mixture
was ¢lter sterilized into a 2.0 ml sterile Nunc tube,
capped and incubated at 37‡C. Aliquots of 50 Wl
were removed in triplicate for each time point at 0,
24, 48, and 72 h and spotted on 2.5 cm 3MM ¢lter
paper discs suspended on pins. After 30 s, each ¢lter
was placed in a basket suspended in 300 ml of ice-
cold 10% trichloroacetic acid (TCA) to precipitate
the protein within the paper disc. At the conclusion
of sampling, each group of discs was washed in a 5%
TCA solution with stirring at room temperature for
15 min, then 5% TCA at 70‡C for 15 min and etha-
nol:ether (2:1) for 15 min to remove TCA and water
from the discs. The discs were dried under an incan-
descent lamp and the protein-bound radioactivity de-
termined in a liquid scintillation spectrometer [25].
Reactions carried out in the absence of sugar rou-
tinely gave less than 50 cpm of [14C]lysine incorpo-
rated. A blank disc was also included with the others,
but no radioactivity was bound to the cellulose dur-
ing the wash procedure. The data were calculated as
nmol lysine incorporated/mg protein in the presence
and absence of di¡erent inhibitors.
The e¡ectiveness of several inhibitors was mea-
sured at increasing concentrations, usually from 0 to
10 mM. Inhibition was measured in a similar manner
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using either 250 mM glucose, 3.0 mM L-threosone or
3.0 mM 3-deoxythreosone in place of L-threose as
the reactive sugar.
2.3. Glycation assay
Reaction mixtures were prepared containing
250 mM [14C]glucose (0.1 mCi/mmol), 5.0 mg bovine
lens proteins, 0.1 mM DTPA, 0.1 M phosphate bu¡-
er, pH 7.0 and increasing concentrations of inhibitor
in a total volume of 1.0 ml. Aliquots of 50 Wl were
taken at weekly intervals, spotted on discs and pro-
cessed as described for the cross-linking assay. Glyc-
ation was reported as nmol glucose incorporated/mg
protein.
2.4. SDS-polyacrylamide gel electrophoresis
Protein cross-linking was determined by the extent
of dimer and polymer formation in protein samples
removed from cross-linking assays carried out in the
absence of added lysine, but in the presence of in-
creasing inhibitor. Aliquots of 0.4 ml were removed
and placed in Millipore Ultrafree MC ¢lter units
(10 kDa cuto¡) and centrifuged at 5000 rpm for
2 h. The ¢lter retentate was washed three times
with 0.25 ml water, redissolved in water and stored
at 380‡C. Protein levels were determined on the col-
lected samples by the BCA protein assay as described
by the manufacturer (Pierce, Rockford, IL). Aliquots
containing 40 Wg of protein were boiled with 20 Wl of
a bu¡er containing 0.5 M Tris bu¡er, pH 6.75, 4%
SDS, 1.4 M MSH, 20% glycerol, 0.2 M glycine and
0.1% Bromphenol blue dye, and subjected to SDS-
polyacrylamide gel electrophoresis [25].
2.5. Fluorescence measurements
Aliquots equivalent to 80 Wg protein were removed
from the cross-linking reaction mixtures described in
Section 2.1, diluted to 2.0 ml with 0.1 M phosphate
bu¡er, pH 7.0 and the £uorescence determined in a
Turner spectro£uorometer at an excitation wave-
length of 360 nm and an emission wavelength of
440 nm. The £uorescence values for the various un-
inhibited reactions were all normalized to 100%. In
several cases, larger aliquots were taken and dialyzed
prior to measuring £uorescence. No less than 70% of
the total £uorescence remained bound to the pro-
teins. No £uorescence was seen in the absence of
added L-threose.
3. Results
3.1. The activity of various reported inhibitors in the
[14C]lysine cross-linking assay
The cross-linking of [14C]lysine to lens proteins by
5.0 mM L-threose was followed for 3 days in the
presence of several reported AGE formation inhibi-
tors each at 10 mM concentration. Fig. 1A shows
that ibuprofen [20], germanium compound [26], as-
pirin [27,28], pyruvic acid ethyl ester (paee) [29], taur-
ine [18] and TEMPO [30] all inhibited 50% or less.
Equivalent data were seen at all 3 days of incubation.
Carnosine [31] and possibly taurine were the only
inhibitors in Fig. 1A that were marginally e¡ective.
Fig. 1B shows the results of a similar assay with
other reported inhibitors. The antioxidant butylated
hydroxytoluene (BHT), Arg, N-acetyl-Arg and nia-
cinamide exhibited little or no inhibitor activity, but
the cofactors thiamine pyrophosphate (TPP) and
pyridoxal phosphate (PLP) inhibited completely as
shown previously [22], as did 2-AG and its analogue,
semicarbazide. The sulfur-containing compounds
were both completely e¡ective.
Increasing levels of PLP and TPP [22] were tested
in the same assay (Fig. 2A). A linear increase in in-
hibition was observed, with 50% inhibition seen at
4 and 6 mM respectively. The concentration required
to attain complete inhibition was greater than the
L-threose present in the reaction mixture. The e¡ec-
tiveness of cysteine in Fig. 1B could have been due to
either competition by the amino group or by the
reactivity of the SH group. The same was true with
glutathione, which was a similarly e¡ective inhibitor
(data not shown). To resolve this we compared the
inhibition by Ser, Ala, N-acetyl-Arg and Cys. Ser
and Ala and N-acetyl Arg inhibited no more than
20% at all concentrations up to 6.0 mM, whereas
Cys inhibited completely at 6.0 mM, with 50% inhi-
bition observed at only 1.0 mM (Fig. 2B). Fig. 2C
shows the e¡ect of increasing inhibitor concentration
with the four most e¡ective inhibitors found. The
dicarbonyl-reactive compounds 2-AG and o-phenyl-
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enediamine (OPD) gave similar inhibition curves,
with 50% inhibition at 1.0 mM concentrations. A
control reaction with increasing dimethyl guanidine
gave 10% inhibition or less at each concentration
(data not shown). Fig. 2C also shows the inhibition
by two sulfur-containing compounds, 3-mercapto-
propionate (3-MP) and sodium metabisul¢te
(MBS). The 3-MP inhibition curve shown was iden-
tical to that for Cys above, whereas metabisul¢te was
almost an order of magnitude more e¡ective, with
50% inhibition observed from 0.1 to 0.2 mM. The
data in Fig. 2C were essentially the same at days 1
and 2, and were repeated at least twice by each of
two investigators. Inhibition curves with 2-AG and
metabisul¢te were also conducted with K-N-formyl-
[14C]lysine in place of [14C]lysine, and no di¡erence
in the inhibition curves was observed. These data are
consistent with our prior report that the K-amino
group of lysine is largely unreactive in this cross-link-
ing assay [23].
Fig. 2. The inhibition of cross-linking by increasing levels of
the e¡ective inhibitors shown in Fig. 1. Panel A shows the re-
sults obtained with PLP and TPP. Panel B shows the inhibition
by several amino acids and panel C shows the inhibition by
2-AG, OPD, 3-mercaptopropionate and sodium metabisul¢te.
Fig. 1. The e¡ect of various reported inhibitors on the cross-
linking of [14C]lysine to lens proteins. Reaction mixtures con-
tained 5.0 mg/ml lens proteins, 5.0 mM L-threose, 2.5 WCi
[14C]lysine, 10 mM inhibitor and 1.0 mM DTPA in 0.1 M
phosphate bu¡er, pH 7.0. Cross-linking was calculated as nmol
of lysine/mg lens protein in the presence and absence of inhibi-
tor. Panels A and B show the di¡erent groups of inhibitors
tested.
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3.2. Cross-linking determined by SDS-PAGE
Cross-linking of proteins can also be determined
by SDS-PAGE, and many investigators use the ac-
cumulation of £uorescence at 360/440 nm as a mea-
sure of cross-linking [32,33]. To con¢rm the e¡ective-
ness of the major inhibitors on the formation of
protein-protein cross-links, lens proteins were incu-
bated with 5.0 L-threose for 3 days and the SDS-
PAGE pro¢les at di¡erent inhibitor levels are shown
in Fig. 3. The subunits of the lens structural proteins
(crystallins) all migrate between 20 and 32 kDa. Con-
siderable dimer formation was seen after 3 days in
the uninhibited reactions (lanes 2 and 9), which was
completely inhibited by high levels of the reducing
agents (upper panel). The relative inhibition of pro-
tein cross-linking corresponds exactly to the incorpo-
ration data shown previously in Fig. 2C. The inhibi-
tion of dimer formation by the dicarbonyl-reactive
compounds (lower panel), however, showed de¢nite
residual cross-linking even at the highest inhibitor
levels. This is especially true in the case of OPD.
Possibly, other residues in the protein can form
cross-links via a mechanism not inhibited by the re-
agents used.
3.3. The e¡ect of inhibitors on £uorescence
Fig. 4 shows the e¡ect of the major inhibitors on
the formation of 360/440 nm £uorescence. Inhibition
was observed at lower inhibitor levels in every case;
however, the inhibition did not increase at higher
concentrations. While the extent of non-inhibitable
£uorescence was di¡erent with each inhibitor, the
inhibition of £uorescence by metabisul¢te was simi-
lar to that seen in Figs. 2C and 3 (upper panel). A
population of non-cross-linked AGEs or non-lysine
cross-links may have been formed, which were £uo-
rescent, but whose synthesis was not inhibited. Since
these samples were not dialyzed, the uninhibited £uo-
rescence may represent low molecular weight AGEs.
Fig. 3. The inhibition of dimer and polymer formation as deter-
mined by SDS-PAGE using increasing levels of various inhibi-
tors. Reactions were carried out for 3 days as described in Fig.
2C, but in the absence of added lysine.
Fig. 4. The e¡ect of increasing levels of various inhibitors on
the formation of 360/440 nm £uorescence. Reactions were iden-
tical to those shown in Fig. 2C.
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Dialysis of several samples of larger volume showed
that 20^30% of the £uorescence was dialyzable.
3.4. The inhibition of cross-linking and glycation in
reactions mediated by glucose
The cross-linking by L-threose was very rapid in
our assays, allowing signi¢cant lysine incorporation
to be measured in only a few days; however, similar
inhibitor activity was observed with glucose as the
glycating sugar. The major inhibitor curves shown
in Fig. 2C were also tested in a reaction containing
250 mM D-glucose in place of L-threose. In these
assays, however, the cross-linking was allowed to
proceed for 3 weeks. Fig. 5 shows that the inhibition
curves after 3 weeks were very similar to those with
L-threose after 3 days, except that a residual cross-
linking was seen in the presence of 2-AG, even at
levels as high as 10 mM. These data suggest that
the inhibitors are either forming a complex with, or
blocking the formation of, a reactive intermediate,
since the inhibitor concentrations used were 1^2 or-
ders of magnitude less than that of the D-glucose
present. Other workers have shown that 2-AG does not
inhibit Amadori compound formation [33]. Each of
the major inhibitors were assayed for their ability to
block the incorporation of [U-14C]glucose into lens
proteins. Incorporation was measured over 3 weeks.
The uninhibited values were 31, 46 and 56 nmol Lys
incorporated/mg protein at 1, 2 and 3 weeks respec-
tively. The inhibition curves for the 3 day time points
are shown in Fig. 6. A slight inhibition was seen with
every inhibitor, but no concentration-dependent in-
hibition was observed. These data argue that the in-
hibition of cross-linking does not occur by blocking
Amadori compound formation. This is consistent
with the fact that these inhibitors are all highly re-
active with dicarbonyl compounds, but these are not
thought to be required for the initial glycation reac-
tion.
3.5. The inhibition of cross-linking with threosone and
3-deoxythreosone as the reactive sugars
The chemical nature of the inhibitors suggests that
the cross-linking of lysine to lens proteins by threose
may proceed through a dicarbonyl sugar intermedi-
ate. To test whether the inhibitors used here were
Fig. 5. The e¡ect of increasing levels of various inhibitors on
the glucose-mediated incorporation of [14C]lysine into lens pro-
teins. Reaction mixtures were identical to those described in
Fig. 2C, except that the 5.0 mM L-threose was replaced with
250 mM glucose. Values shown were obtained after 3 weeks of
incubation at 37‡C.
Fig. 6. The e¡ect of increasing levels of various inhibitors on
the incorporation of [14C]glucose into lens proteins. Reactions
were those described in Fig. 1 except that they contained 250
mM [14C]glucose (0.1 mCi/mmol) in place of L-threose and
[14C]lysine.
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also e¡ective in inhibiting dicarbonyl sugar-induced
cross-linking, both 3-deoxythreosone and threosone
were prepared and assayed for their cross-linking
activity. Fig. 7A shows the inhibition curves obtained
with 3 mM 3-deoxythreosone in place of 5.0 mM
threose. The reducing agents were only slightly less
e¡ective, but the dicarbonyl-reactive agents were
markedly poorer inhibitors. Fig. 7B shows similar
inhibition curves for the reactions with 3.0 mM
threosone as the reacting sugar. All inhibitors were
less e¡ective, and o-phenylenediamine was unable to
inhibit 50% even at 10 mM. The dicarbonyl inhibi-
tors were both less e¡ective when high levels of the
dicarbonyl sugar were added initially to the reaction,
presumably due to the fact that 3.0 mM dicarbonyl
sugar is a much higher concentration than that
formed by the breakdown or oxidation of threu-
lose-lysine in the threose-mediated cross-linking as-
say.
4. Discussion
A close correlation exists between serum glucose
levels and diabetic complications. Many laboratories
are investigating whether the major damaging e¡ects
of elevated glucose are exerted by the formation of
AGEs in the a¡ected tissues. This research has
prompted a search for compounds that could inhibit
AGE formation, as they could be of particular ben-
e¢t in the treatment of diabetic cataract, where pro-
tein cross-links and £uorophores appear commensu-
rate with the duration of the disease.
While 2-AG requires high systemic levels to be an
e¡ective AGE inhibitor, it can be employed success-
fully in animal models due to its high solubility and
lack of signi¢cant side e¡ects [34,35]. A variety of
other compounds have been suggested as AGE for-
mation inhibitors, but their activities have not been
studied in a quantitative manner. The sugar-depen-
dent incorporation of [14C]lysine provides a conven-
ient assay to speci¢cally measure lysine-protein cross-
link formation and to screen for cross-linking inhib-
itors. Because most known cross-links involve lysine,
because the incorporation can be readily quanti¢ed
and because the assay system can be employed with
any glycating sugar, it is universally applicable to
these kinds of study.
The majority of the inhibitors previously reported
in the literature exhibited only marginal activity even
at 10 mM; however, several inhibited completely.
2-AG, semicarbazide and OPD are dicarbonyl-reac-
tive compounds and were able to inhibit 50% at 1^
2 mM. These data argue that dicarbonyl sugars may
play a signi¢cant role in cross-linking with threose as
the glycating sugar. When threosone and 3-deoxy-
threosone were used as the glycating agent, 2-AG
and OPD were markedly less e¡ective, likely due to
the higher levels of dicarbonyl in these reactions.
Consistent with the work of Shin et al. [36] and
Kato et al. [37], which implicate 3-deoxyglucosone
as the cross-linking agent in systems containing
with glucose, the dicarbonyl inhibitors gave similar
inhibition curves with glucose. In these reactions,
however, 250 mM glucose was employed over a 3
week incubation time in order to observe signi¢cant
cross-linking. Since the inhibitors were e¡ective at
only 1^2 mM, they cannot be reacting with the sug-
ar, but could be su⁄cient to react with any 3-deoxy-
Fig. 7. The e¡ect of increasing levels of various inhibitors on
the cross-linking of [14C]lysine into lens proteins. The reaction
conditions were those described in Fig. 2C except that the
5.0 mM L-threose was replaced by either 3.0 mM 3-deoxythreo-
sone (A) or 3.0 mM threosone (B).
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glucosone formed. Threosone was almost 10-fold less
active in cross-linking lysine to proteins than 3-de-
oxythreosone, as reported previously [14]. The in-
creased activity of 3-deoxythreosone, and its ease of
formation from threulose-lysine, make it the better
candidate for cross-linking in the threose reaction.
Also, a chelating agent was present in all the incu-
bations, preventing the oxidative breakdown of
threulose-lysine to produce threosone.
The dicarbonyl-reactive inhibitors did not inhibit
glycation by glucose. There was a slight decrease in
incorporation, which was seen at each weekly time
point. This may represent a very reactive component
in the [14C]glucose, which was not diluted by a sim-
ilar compound in the [12C]glucose, and therefore had
a much higher speci¢c radioactivity than glucose.
This e¡ect has been reported by others [38], and
may represent a glyceraldehyde impurity. The
cross-linking assay employed here gave results simi-
lar to the extent of dimer and polymer formation
seen by SDS-PAGE. Similarly, the inhibitor activity
showed decreasing cross-linking with increasing con-
centration, consistent with the [14C]lysine incorpora-
tion. The dicarbonyl inhibitors, however, showed
de¢nite dimer formation even at the highest levels
tested. These data suggest that there may be cross-
links formed between proteins not involving lysine,
which do not proceed via a dicarbonyl intermediate.
In previous work we were able to show that threose
was very active in cross-linking K-N-acetyl-
[14C]arginine to lens proteins [39]. Since many of
the lens crystallins are multisubunit proteins, a
cross-link precursor may react with a juxtaposed res-
idue in an adjacent subunit before the inhibitor can
interact. Many laboratories studying AGE formation
in tissues use 360/440 nm £uorescence as an indicator
of cross-linking [40]. The data in Fig. 4 show that the
cross-linking inhibitors were markedly less e¡ective
inhibiting £uorescence formation, especially at higher
inhibitor levels. Since we are measuring total AGE
£uorescence, the residual protein-protein cross-links,
seen in the SDS-PAGE gels in Fig. 3 could contrib-
ute to the resistant £uorescence. It is more likely,
however, that many £uorescent AGEs are formed,
which are not cross-links.
To avoid possible competitive inhibition by the
presence of amino groups, we employed the cysteine
analogue, 3-mercaptopropionate, which was as e¡ec-
tive as cysteine as an inhibitor. Of all the inhibitors,
sodium metabisul¢te was an order of magnitude
more e¡ective. Bisul¢te is historically known as an
inhibitor of the browning reaction [41]. Wedzicha
[42] has reported that the bisul¢te reacts with ad-
vanced intermediates in the browning reaction, pos-
sibly 3-deoxyglucosone, to form 3,4-dideoxy-4-sulfo-
hexosulose. The sulfation of the OH group on
carbon 4 may be most signi¢cant to its inhibitor
activity, because this carbon was shown to be impor-
tant for AGE cross-linking [39]. Therefore, bisul¢te
is a more e¡ective inhibitor due to its enhanced abil-
ity as a dicarbonyl trapping agent. Sulfhydryl com-
pounds also form a complex with dicarbonyls, but
these adducts are reversible. The possibility that
these compounds are acting as reducing agents, how-
ever, cannot be ruled out [43].
A plausible mechanism for threose cross-linking
involves an initial formation of threulose-lysine,
which rapidly dissociates to 3-deoxythreosone. This
osone could react with either lysine [12] or arginine
[39,44,45], forming an intermediate, which then re-
quires an additional step or steps to form a cross-
link. Many steps are likely involved in the latter re-
action given the complexity of the AGE products
produced with threose [46].
Since the levels of the 3-deoxyosones are likely
much higher in our in vitro assay than those occur-
ring in vivo during aging, lower levels of the inhib-
itors than those employed here may be e¡ective in
the whole animal. The e¡ectiveness of cysteine and
glutathione also argues that these natural antioxi-
dants may represent signi¢cant endogenous inhibi-
tors, acting as dicarbonyl trapping agents. AGE pre-
vention by these inhibitors would markedly decrease,
however, as these compounds become increasingly
oxidized during aging and diabetes.
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